Related Experiment Videos
Variation of therapeutic response in Parkinson's disease: a retrospective study
G Geminiani1, B M Cesana, G Scigliano
1Department of Neurology, National Neurological Institute C. Besta, Milan, Italy.
Abstract:
A retrospective study of variations of therapeutic response (dyskinesia and on-off phenomenon) in Parkinson's disease was conducted on 278 patients treated with levodopa for at least 6 months and hospitalized at National Neurological Institute "C. Besta" of Milan between 1974 and 1984. Variations of therapeutic response (TRV) were present in 105 of 278 patients; in this group, age at illness onset was significantly lower, while duration of levodopa treatment and also duration of illness were longer than in the group of patients without TRV. Multiple logistic regression analysis showed that the most important variables were age at illness onset and duration of treatment, but they were only modestly predictive. Other factors connected with progression of disease must also contribute to the TRV.
Insights
Therapeutic response variations (TRV) in Parkinson's disease patients treated with levodopa were analyzed. Lower age at onset and longer treatment duration were linked to TRV, though not highly predictive.
Area of Science:
- Neurology
- Neuroscience
- Movement Disorders
Background:
- Parkinson's disease (PD) management often involves levodopa.
- Variations in therapeutic response, including dyskinesia and the on-off phenomenon, are common challenges.
- Understanding factors influencing these variations is crucial for optimizing PD treatment.
Purpose of the Study:
- To investigate factors associated with therapeutic response variations (TRV) in Parkinson's disease patients receiving levodopa.
- To identify predictors of dyskinesia and on-off phenomena in a long-term levodopa-treated cohort.
Main Methods:
- Retrospective analysis of 278 Parkinson's disease patients treated with levodopa for at least six months.
- Data collected from patients hospitalized between 1974 and 1984 at the National Neurological Institute 'C. Besta' in Milan.
- Statistical analysis, including multiple logistic regression, to identify significant variables related to TRV.
Main Results:
- Therapeutic response variations (TRV) were observed in 105 out of 278 patients.
- Patients with TRV had a significantly lower age at illness onset compared to those without TRV.
- Longer duration of levodopa treatment and longer overall illness duration were also associated with TRV.
Conclusions:
- Age at illness onset and duration of levodopa treatment are significant, albeit modestly predictive, factors for TRV in Parkinson's disease.
- Additional factors related to disease progression likely contribute to the development of therapeutic response variations.
- Further research is needed to fully elucidate the multifactorial nature of levodopa treatment complications in PD.